DSM-Firmenich 

€93.64
275
+€0.54+0.58% Monday 15:29

Statistics

Day High
93.64
Day Low
91.74
52W High
96.6
52W Low
63.1
Volume
2,538
Avg. Volume
-
Mkt Cap
23.55B
P/E Ratio
-
Dividend Yield
0.92%
Dividend
0.86

Upcoming

Dividends

0.92%Dividend Yield
May 26
€0.86
May 26
€1.64
May 25
€1.44
May 25
€1.06
May 24
€0.93
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-18.87%

Earnings

30JulExpected
Q2 2025
Q4 2025
Q2 2026
0.83
1.32
1.81
2.3
Expected EPS
1.719364706052
Actual EPS
1.179276080808

Financials

-8.63%Profit Margin
Unprofitable
2023
2024
2025
12.52BRevenue
-1.08BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZX6.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
International Flavors & Fragrances
IFF
Mkt Cap22.03B
International Flavors & Fragrances competes directly in the creation of flavors, fragrances, and cosmetic actives, similar to DSM-Firmenich's portfolio.
Symrise
SYIEY
Mkt Cap14.21B
Symrise operates in the same sectors as DSM-Firmenich, offering flavors, fragrances, cosmetic ingredients, and nutritional products.
Sensient Technologies
SXT
Mkt Cap5.74B
Sensient Technologies Corporation specializes in colors, flavors, and fragrances, making it a direct competitor in several of DSM-Firmenich's key markets.
Takeda Pharmaceutical
TAK
Mkt Cap58.92B
Takeda Pharmaceutical, through its biotech and life sciences divisions, competes in the nutritional and health solutions space, overlapping with DSM-Firmenich's health segment.
Archer Daniels Midland
ADM
Mkt Cap40.78B
Archer-Daniels-Midland Company is a major player in the agricultural and nutritional sectors, competing with DSM-Firmenich in food ingredients and health products.
Basf
BASFY
Mkt Cap47.72B
BASF operates in the chemicals sector, including nutrition and health, which puts it in competition with DSM-Firmenich in several areas, including ingredients for health and wellness products.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap282.73M
Before the merger, DSM was a standalone competitor in the health, nutrition, and materials science sectors, competing in areas that overlap with Firmenich's portfolio.
Campbells Co)
CPB
Mkt Cap6.38B
Campbell Soup Company, through its health and wellness initiatives and food products, competes indirectly with DSM-Firmenich in the nutrition and ingredients sector.
Natural Grocers by Vitamin Cottage
NGVC
Mkt Cap643.67M
Natural Grocers by Vitamin Cottage offers a range of natural and organic products, including nutritional supplements, competing in the health and wellness retail sector against DSM-Firmenich's nutritional products.

About

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.
Show more...
CEO
Country
Switzerland
ISIN
CH1216478797
WKN
000A3D2TK

Listings

0 Comments

Share your thoughts

FAQ

What is DSM-Firmenich stock price today?
The current price of ZX6.XETRA is €93.64 EUR — it has increased by +0.58% in the past 24 hours. Watch DSM-Firmenich stock price performance more closely on the chart.
What is DSM-Firmenich stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange DSM-Firmenich stocks are traded under the ticker ZX6.XETRA.
What is DSM-Firmenich market cap?
Today DSM-Firmenich has the market capitalization of 23.55B
When is the next DSM-Firmenich earnings date?
DSM-Firmenich is going to release the next earnings report on February 18, 2027.
What were DSM-Firmenich earnings last quarter?
ZX6.XETRA earnings for the last quarter are 1.18 EUR per share, whereas the estimation was 1.72 EUR resulting in a -31.41% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is DSM-Firmenich revenue for the last year?
DSM-Firmenich revenue for the last year amounts to 12.52B EUR.
What is DSM-Firmenich net income for the last year?
ZX6.XETRA net income for the last year is -1.08B EUR.
Does DSM-Firmenich pay dividends?
Yes, ZX6.XETRA dividends are paid annual. The last dividend per share was 0.86 EUR. As of today, Dividend Yield (FWD)% is 0.92%.
In which sector is DSM-Firmenich located?
DSM-Firmenich operates in the Other sector.
When did DSM-Firmenich complete a stock split?
DSM-Firmenich has not had any recent stock splits.